Turner's syndrome

4 trials 5 recruiting MedDRA PT
4 Registered trials
5 Recruiting
3 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
M Musculoskeletal (ATC M) 1
N Neurology/Psychiatry (ATC N) 1
— ATC code not specified 1
G Urology/Gynaecology (ATC G) 4
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase III: 1 Phase II: 1 Phase IV: 4

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

1 trial
  • Novo Nordisk A/S Commercial
    SOMAPACITAN
    2022-501055-87-01 3 countries 2023 n=20 Orphan
    Ended

Phase II

1 trial
  • Biomarin Pharmaceutical Inc. Commercial
    VOSORITIDE
    2024-515861-33-00 4 countries 2025 n=40 Orphan
    Recruiting

Phase IV

4 trials
  • Region Midtjylland Academic
    ESTRADIOL
    2024-518001-18-00 1 country 2021 n=100
    Recruiting
  • Region Midtjylland Academic
    ESTRADIOL
    2024-518557-42-00 1 country 2021 n=50
    Recruiting
  • Region Midtjylland Academic
    ESTRADIOL
    2024-518001-18-00 1 country 2021 n=100
    Recruiting
  • Region Midtjylland Academic
    ESTRADIOL
    2024-518557-42-00 1 country 2021 n=50
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Region Midtjylland Academic 4 Phase IV 4
Biomarin Pharmaceutical Inc. Commercial 1 Phase II 1
Novo Nordisk A/S Commercial 1 Phase III 0
New trials by year
2021
4
2023
1
2025
1
← All indication landscapes